MedTrace Logo

Long-term Effect of Steroid on Metabolic Diseases in Asthmatics

NCT06279078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19968

Last updated 2025-11-17

No results posted yet for this study

Summary

The goal of this retrospective/observational study is to compare the clinical outcomes between the high-cumulative-dose group and the low- cumulative-dose group of oral/inhaled corticosteroid in the long-term management of asthma patients. The main hypothesis are:

i. High cumulative dose of corticosteroid is related to the prevalence of osteoporosis/osteoporosis in the long-term management of adult asthma.

ii. High cumulative dose of corticosteroid can affect populations that have a high-risk of osteoporosis (females over 50 years of age).

iii. High cumulative dose of corticosteroid is related to the prevalence of diabetes mellitus, hypertension, and hyperlipidemia in the long-term management of adult asthma.

iv. High cumulative dose of corticosteroid affects bone metabolism-related diagnostic tests and laboratory values and the prescription rate of bone metabolism-related medications.

Conditions

  • Asthma
  • Osteoporosis, Osteopenia
  • Osteoporosis Risk
  • Osteoporotic Fractures

Interventions

DRUG

Corticosteroid

oral/inhaled corticosteroid

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Ajou University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-30
Primary Completion
2024-12-30
Completion
2025-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06279078 on ClinicalTrials.gov